Skip to main content
Tech.euFundingExplorerBeta

A4Cell

A4Cell has developed SPAchip®, a technology that responds to one of the technological challenges we face today: to fully understand cell physiology.

A4Cell has raised €4.3M across 2 funding rounds from 6 investors, most recently a round in Nov 2023. Based in Madrid, Spain; active in Deeptech. Data as of 28 Oct 2026.

Total raised
€4.3M
€4,250,000
Funding rounds
2
Investors
6
distinct backers
Active since
2021-12
latest 2023-11

Funding by year

EUR raised per year
A4Cell — funding by year — interactive chart.
Data table
A4Cell — funding by year
2021€1.3M
2023€3.0M

Signals

High confidence
Raise-next likelihood6
base rate 30% for Other
  • ▼ Past typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
  • ▲ 5y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds

Similar companies

same sector or country

Global coverage: FundingData